Experimental evidence, using Gal-3−/− mice indicate that in vivo Gal-3 administration causes glucose intolerance and insulin resistance whereas in vitro treatment with selective small molecule Gal-3 inhibitors can directly induce decreased insulin sensitivity in myocytes, hepatocytes, and adipocytes [349]. This evidence concerns the gene LGALS3 and Insulin resistance.